autologous mesenchymal stem cells implantation
AMSC-01-HMO-CTIL
Phase 2 other completed
Quick answer
autologous mesenchymal stem cells implantation for Tibial Fracture is a Phase 2 program (other) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Tibial Fracture
- Phase
- Phase 2
- Modality
- other
- Status
- completed